A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors

✍ Scribed by Pant, Shubham; Burris, Howard A.; Moore, Kathleen; Bendell, Johanna C.; Kurkjian, Carla; Jones, Suzanne F.; Moreno, Ofir; Kuhn, John G.; McMeekin, Scott; Infante, Jeffrey R.

• Book ID: 121558172
• Publisher: Springer US
• Year: 2013
• Tongue: English
• Weight: 176 KB
• Volume: 32
• Category: Article
• ISSN: 0167-6997
• DOI: 10.1007/s10637-013-9949-4